Action Biocartis Group NV - BCART

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

0,29

Prix Achat

0,30

Prix Vente

0,09

Volume échangé

0,00

0,00 Fourchette du Jour 0,00

0,29 Plage de 52 semaines 0,29

Clôture Veille

0,29

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

0,00

Volume financier

VWAP

Press release Biocartis Group NV: Biocartis Group NV provides an update regarding the publication of its annual report and the annual meeting

Press release Biocartis Group NV: Biocartis Group NV provides an update regarding the publication of its annual report and the annual meeting...

Press release Biocartis Group NV: Disclosure of transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of major shareholdings)

Press release Biocartis Group NV: Disclosure of transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the...

Press release Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansion

Press release Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansion PRESS RELEASE - 22 November 2023, 10:00 CET...

Press release Biocartis NV: Biocartis Hosts Corporate Workshop and Announces Seven Idylla™ Abstracts to be Presented at AMP 2023 Annual Meeting

Press release Biocartis NV: Biocartis Hosts Corporate Workshop and Announces Seven Idylla™ Abstracts to be Presented at AMP 2023 Annual Meeting...

Press release Biocartis Group NV: Announcement regarding Enforcement by Secured Creditors

Press release Biocartis Group NV: Announcement regarding Enforcement by Secured Creditors PRESS RELEASE REGULATED INFORMATION 31 October...

Press release Biocartis Group NV: Four Abstracts Showing Excellent Data for Idylla™ Presented at European Society of Molecular Oncology Congress (ESMO)

Press release Biocartis Group NV: Four Abstracts Showing Excellent Data for Idylla™ Presented at European Society of Molecular Oncology...

Press release Biocartis Group NV: Biocartis Honors Breast Cancer Awareness Month with Launch of Breast Cancer Portfolio

Press release Biocartis Group NV: Biocartis Honors Breast Cancer Awareness Month with Launch of Breast Cancer Portfolio PRESS RELEASE 16...

Press release Biocartis Group NV: Biocartis Announces Expansion of its Collaboration with APIS Assay Technologies to Commercialize the APIS ESR1 Mutations Kit

Press release Biocartis Group NV: Biocartis Announces Expansion of its Collaboration with APIS Assay Technologies to Commercialize the APIS...

Press Release Biocartis Group NV: Disclosure of transparency notification

Press Release Biocartis Group NV: Disclosure of transparency notification PRESS RELEASE: REGULATED INFORMATION ...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0.29	0.29	0.29	0	0	DE
4	0	0	0.29	0.29	0.29	0	0	DE
12	0	0	0.29	0.29	0.29	0	0	DE
26	0	0	0.29	0.29	0.29	0	0	DE
52	0	0	0.29	0.29	0.29	0	0	DE
156	-2.07	-87.7118644068	2.36	2.365	0.285	65894	0.75069289	DE
260	-5.45	-94.9477351916	5.74	5.89	0.285	78202	2.26622181	DE

BCART - Frequently Asked Questions (FAQ)

What is the current Biocartis Group NV share price?

The current share price of Biocartis Group NV is 0,29 €

What is the 1 year trading range for Biocartis Group NV share price?

Biocartis Group NV has traded in the range of 0,29 € to 0,29 € during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
ALSENSensorion	0,2092 € (34,53%)	2,23M
EBUSEbusco Holding NV	0,6485 € (27,66%)	5,29M
MLFXOFinaxo	2,26 € (19,58%)	808
MLSMLSmalto	0,015 € (15,38%)	2k
ALLDLLDLC Groups	7,70 € (14,93%)	24,07k
PHXMPHAXIAM Therapeutics SA	0,1515 € (-73,88%)	234,8k
ALCHIAlchimie	0,231 € (-42,25%)	365,3k
ALNEVNeovacs	0,013 € (-23,08%)	3,18M
ALOKWGroupe Okwind SA	1,57 € (-21,18%)	61,01k
MLNMAMiguet Et Associes	0,15 € (-20,21%)	250
ALEUPEuroplasma	0,017 € (11,11%)	326,62M
ALVERVergnet	0,0007 € (0,00%)	294,39M
ALALOAcheterLouerFR	0,0004 € (-20,00%)	270,92M
ALHPIHopium SA	0,0009 € (-10,00%)	109,33M
BCPBanco Comercial Portugues SA	0,5684 € (1,97%)	57,02M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Biocartis Group NV (BCART)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

BCART Dernières nouvelles

Press release Biocartis Group NV: Biocartis Group NV provides an update regarding the publication of its annual report and the annual meeting

Press release Biocartis Group NV: Disclosure of transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of major shareholdings)

Press release Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansion

Press release Biocartis NV: Biocartis Hosts Corporate Workshop and Announces Seven Idylla™ Abstracts to be Presented at AMP 2023 Annual Meeting

Press release Biocartis Group NV: Announcement regarding Enforcement by Secured Creditors

Press release Biocartis Group NV: Four Abstracts Showing Excellent Data for Idylla™ Presented at European Society of Molecular Oncology Congress (ESMO)

Press release Biocartis Group NV: Biocartis Honors Breast Cancer Awareness Month with Launch of Breast Cancer Portfolio

Press release Biocartis Group NV: Biocartis Announces Expansion of its Collaboration with APIS Assay Technologies to Commercialize the APIS ESR1 Mutations Kit

Press Release Biocartis Group NV: Disclosure of transparency notification

Press release Biocartis Group NV: Biocartis Group NV provides an update regarding the publication of its annual report and the annual meeting

BCART - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Biocartis Group NV (BCART) Cours

Biocartis Group NV (BCART)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

BCART Dernières nouvelles

Press release Biocartis Group NV: Biocartis Group NV provides an update regarding the publication of its annual report and the annual meeting

Press release Biocartis Group NV: Disclosure of transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of major shareholdings)

Press release Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansion

Press release Biocartis NV: Biocartis Hosts Corporate Workshop and Announces Seven Idylla™ Abstracts to be Presented at AMP 2023 Annual Meeting

Press release Biocartis Group NV: Announcement regarding Enforcement by Secured Creditors

Press release Biocartis Group NV: Four Abstracts Showing Excellent Data for Idylla™ Presented at European Society of Molecular Oncology Congress (ESMO)

Press release Biocartis Group NV: Biocartis Honors Breast Cancer Awareness Month with Launch of Breast Cancer Portfolio

Press release Biocartis Group NV: Biocartis Announces Expansion of its Collaboration with APIS Assay Technologies to Commercialize the APIS ESR1 Mutations Kit

Press Release Biocartis Group NV: Disclosure of transparency notification

Press release Biocartis Group NV: Biocartis Group NV provides an update regarding the publication of its annual report and the annual meeting

BCART - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Abonnez-vous à un compte ADVFN en remplissant le formulaire ci-dessous!

Supprimer les publicités